IV Ketamine: A Possible 'Trajectory of Improvement' in Severe Depression - Medpage Today

Off-label use delivered promising outcomes versus intranasal esketamine in retrospective study

Intravenous ketamine may hold potential advantages over esketamine spray (Spravato) for improving severe depression in a clinical setting, a comparative analysis suggested. In the retrospective stud… [+4892 chars]

full article...